Google DeepMind's Gemini Ultra has demonstrated unprecedented accuracy in analyzing complex biomedical literature, helping researchers identify promising drug targets 40% faster than traditional methods. The advancement marks a significant step toward AI-assisted pharmaceutical research at scale.
Read storyGoogle DeepMind's latest protein folding AI has enabled pharmaceutical partners to identify promising drug candidates for rare diseases in months rather than years. Early results suggest the system could revolutionize treatment development for conditions affecting fewer than 200,000 people globally.
A study across 12,000 patients found that subtle changes in word-finding, sentence structure, and pause patterns are detectable by AI years before symptoms become apparent to patients or doctors.
Computer vision systems mounted on tractors identify individual weeds and spray only where needed. The largest field trial in agricultural history shows it works at scale.
A three-year clinical trial across 17 European hospitals found that AI-assisted mammography screening caught cancers that two independent radiologists missed - without increasing false positive rates.
Jobs quietly automated. Sourced, dated, cumulative.
| Company | Count | |
|---|---|---|
| Klarna | 700 | |
| IBM | 7,800 | |
| BT Group | 10,000 | |
| UnitedHealth Group | 3,200 | |
| Chegg | 1,100 |
100% objective reporting. No ads. No sponsors. No paywall.
One email per week. Both the constructive and concerning sides of AI.